ライフサイエンスコーパス: pregnancy

1 ast two viral loads in the year after end of pregnancy).

2 cies) and 1 374 982 women without (1 524 077 pregnancies).

3 e increase in maternal thyroid volume during pregnancy.

4 management of cardiovascular disease during pregnancy.

5 ing, which avoided the dietary effect during pregnancy.

6 6,800, or 28,000 IU of vitamin D3 throughout pregnancy.

7 ditions experienced during the last third of pregnancy.

8 en exposed to the hormonal changes unique to pregnancy.

9 ue fetal cardiovascular dysfunction in risky pregnancy.

10 ns contribute to gut microbial shifts during pregnancy.

11 an alternative tool for HIV screening during pregnancy.

12 se with gingivitis in mid and late stages of pregnancy.

13 sive protection via maternal immunization in pregnancy.

14 s vital for establishment and maintenance of pregnancy.

15 in those infected in the first trimester of pregnancy.

16 t women who smoke should quit smoking before pregnancy.

17 bidity increases gradually after 41 weeks of pregnancy.

18 exposure prophylaxis (PEP) for plague during pregnancy.

19 with either raltegravir or efavirenz in late pregnancy.

20 l exposure to any bacterial infection during pregnancy.

21 onditions of preeclampsia compared to normal pregnancy.

22 The incidence is between 0.025-0.1% for each pregnancy.

23 pression, to cure placental disorders during pregnancy.

24 l drug for IPTp that could be taken early in pregnancy.

25 -based regimen, including in women intending pregnancy.

26 aternal exposure to PM in ambient air during pregnancy.

27 uld be avoided during the first trimester of pregnancy.

28 er a birth may reflect biological effects of pregnancy.

29 population show limitations for diagnosis in pregnancy.

30 trols had mothers who were vaccinated during pregnancy.

31 lantation, plays a crucial role during early pregnancy.

32 impact on recovery of the vaginal wall from pregnancy.

33 England for women between 28 and 32 weeks of pregnancy.

34 nant women as participants or do not address pregnancy.

35 thelium and for proper alveologenesis during pregnancy.

36 inhibitor to efavirenz when initiated during pregnancy.

37 dinal dataset studying the microbiome during pregnancy.

38 had a lower education level or smoked during pregnancy.

39 ed prenatal care in their first trimester of pregnancy.

40 malaria infection (and its sequelae) during pregnancy.

41 lacental samples from normal and complicated pregnancies.

42 distinguishable between healthy and failing pregnancies.

43 sorders of pregnancy, and multiple gestation pregnancies.

44 d not differ between healthy and complicated pregnancies.

45 ther and grandmother had smoked during their pregnancies.

46 ave no center-specific policy to manage such pregnancies.

47 s to study mechanisms resulting in aneuploid pregnancies.

48 of cases of pre-eclampsia and 2.2% of other pregnancies.

49 ge was 31 years, and 95% had 1 or more prior pregnancies.

50 and 3.4 days respectively, among "low risk" pregnancies.

51 od short-term outcomes that allow uneventful pregnancies.

52 e more obvious in a limited sampling of twin pregnancies.

53 iciency virus (HIV) infection and unintended pregnancies.

54 95 (2.9%) pregnancies and GHTN in 561 (3.3%) pregnancies.

55 ants born to women infected with ZIKV during pregnancy(15-20), highlighting the clinical importance o

56 cy outcome was available in 336 (55%) of 614 pregnancies: 188 (56%) livebirths, 74 (22%) miscarriages

57 A total of 172 of 5673 pregnancies (3%) resulted in pregnancy loss; after the e

58 tral lymphoid organ, changes markedly during pregnancy(3).

59 ad comprehensive echocardiograms and, during pregnancy, 4% filled potentially teratogenic or fetotoxi

60 ied, of which 465 (50%) were associated with pregnancy; 406 of the pregnancy-associated cases (87%) o

61 Overall, 3.6% of pregnancies (47 of 1,315) were complicated by SCEs.

62 ntified 1193 reports of DOAC exposure during pregnancy: 49 from physicians, 48 from the ISTH registry

63 l or surgical history; no evidence of recent pregnancy, abortion, or breastfeeding; and no family his

64 family (syngnathids) that have evolved male pregnancy across a gradient from external oviparity to i

65 ed in pregnancy loss; after the exclusion of pregnancies affected by birth defects, 409 of 5426 (8%)

66 Pregnancy after breast cancer does not increase the risk

67 ate the possibility, safety, and outcomes of pregnancy after TMVI in this population.

68 ects may occur through maternal responses to pregnancy, altered maternal behavior, epigenetic modific

69 antimicrobials considered for plague during pregnancy (amikacin, gentamicin, plazomicin, streptomyci

70 sk of PTD associated with PM exposure during pregnancy among primiparas of Han ethnicity.

71 d estimating equations to account for repeat pregnancies and adjusting for potential confounders.

72 Pre-eclampsia was reported in 495 (2.9%) pregnancies and GHTN in 561 (3.3%) pregnancies.

73 onally, although mothers invest two years in pregnancy and a further three to five years into lactati

74 escribed with psychotropic medication during pregnancy and are associated with antepartum hospitaliza

75 ouse fetal MCs phenotypically mature through pregnancy and can be sensitized by maternal IgE.

76 s codes >30 days apart documented outside of pregnancy and categorized as severe or nonsevere.

77 died interactions of PRS with smoking during pregnancy and childhood life events in relation to CU-tr

78 e, have an increased risk of bleeding during pregnancy and delivery.

79 he uterus and its vasculature, anchoring the pregnancy and ensuring adequate blood flow to the fetus.

80 amic changes in the maternal lipidome during pregnancy and identified lipids associated with Fenton B

81 quine were assessed during each trimester of pregnancy and in the cord blood, providing unambiguous a

82 d an inverse relationship between unintended pregnancy and income, whereas abortion rates varied non-

83 ivation of the maternal immune system during pregnancy and increased risk of neurodevelopmental psych

84 were allowed to deliver normally to measure pregnancy and neonatal outcomes, with a subset sacrifice

85 are for pregnant women with cirrhosis during pregnancy and postpartum to optimize outcomes.

86 were based on scored scales administered in pregnancy and postpartum.

87 012), we included 607 women with a singleton pregnancy and PPROM at 24-29 weeks' gestation, of whom 1

88 erved nonlinear associations between PFOA in pregnancy and some measures of adiposity.

89 presence of periodontal inflammation during pregnancy and subsequent PLBW.

90 During pregnancy and the first year postpartum, 64% (n = 19,344

91 the clinical characteristics of COVID-19 in pregnancy and the intrauterine vertical transmission pot

92 role in the maintenance of a normal healthy pregnancy and we would hypothesize that it may act to pr

93 We identified 2056 women with CHD (2334 pregnancies) and 1 374 982 women without (1 524 077 preg

94 ion at preconception (on average 4 mo before pregnancy) and 8 weeks of gestation.

95 n efavirenz-based regimen in women intending pregnancy, and a dolutegravir-based regimen in others, a

96 utic doses is the treatment of choice during pregnancy, and anticoagulation (LMWH or vitamin K antago

97 [TMP-SMX]) and abstracted data on maternal, pregnancy, and fetal/neonatal outcomes.

98 mmation triggered by viral infections during pregnancy, and its potential downstream pathological eff

99 lder maternal age, hypertensive disorders of pregnancy, and multiple gestation pregnancies.

100 dex z scores, maternal education, smoking in pregnancy, and prenatal particulate matter with diameter

101 36th week of gestation with a live singleton pregnancy, and receiving the diagnosis of undifferentiat

102 oke before pregnancy continue smoking during pregnancy, and some start to quit smoking after being pr

103 citing causes, but so were somatic diseases, pregnancy, and substance abuse.

104 Additionally, we found that pregnancy- and puberty-associated accentuation of vascul

105 hat poor outcomes from ZIKV infection during pregnancy are due in part to pregnancy-induced alteratio

106 omes, yet iron homeostatic mechanisms during pregnancy are poorly understood.

107 covering the preconception period and early pregnancy are urgently needed to better protect pregnant

108 ing to increase LARC use or reduce unplanned pregnancies around the same time could also explain the

109 TDM is useful in several situations, such as pregnancy, as well as when there are compliance issues.

110 ) were associated with pregnancy; 406 of the pregnancy-associated cases (87%) occurred in neonates.

111 f induction of labour (IOL) in uncomplicated pregnancies at 41 weeks will improve perinatal outcomes.

112 recruited between 2009 and 2014 from the UK Pregnancies Better Eating and Activity Trial (UPBEAT), a

113 n-based study of 1,753,865 Medicaid-eligible pregnancies between January 2000 and December 2013.

114 c regression was used to compare the odds of pregnancy between cases and controls.

115 ain (GWG) and preterm birth according to pre-pregnancy body mass index (BMI) and maternal age.

116 ial, leading many families to decline future pregnancies, but the potential impact of assessing paren

117 Viral infections during pregnancy can have devastating consequences on pregnancy

118 or reinfection with new virus strains during pregnancy can result in fetal infection.

119 clampsia, a life-threatening complication of pregnancy characterised by hypertension and elevated sol

120 sociodemographic risk factors in a high-risk pregnancy cohort (n = 122) in Chapel Hill, North Carolin

121 econdary analysis used data of a prospective pregnancy cohort study included apparently healthy adult

122 onfirmed in maternal blood from preeclamptic pregnancies compared with controls.

123 Characterization of HLA-G+ EVT from term pregnancy compared to first trimester revealed their uni

124 Anti-SSA/Ro-positive mothers with a previous pregnancy complicated by CHB were recruited (n = 19 Stag

125 patients who gave birth (76.9%; 170 babies), pregnancy complications and congenital anomalies occurre

126 Maternal diabetes can lead to pregnancy complications and impaired fetal development.

127 Shallow invasion increases the risk of pregnancy complications, e.g., severe preeclampsia.

128 In women seronegative before pregnancy, congenital cytomegalovirus (cCMV)-related seq

129 Most of the women who smoke before pregnancy continue smoking during pregnancy, and some st

130 analysis of vaginal swabs, taken throughout pregnancy, could predict which women go on to deliver pr

131 In this study, dNK from human term pregnancy decidua basalis and decidua parietalis tissues

132 During early pregnancy, decidual innate lymphoid cells (dILCs) intera

133 Lipid metabolism in pregnancy delivers PUFAs from maternal liver to the deve

134 determined that inflammation can counteract pregnancy-dependent suppression of maternal hepcidin.

135 had little impact on incidence or timing of pregnancy detection.

136 sis to vaccination in the first trimester of pregnancy did not influence risk estimates (aHR, 0.92 [C

137 Early pregnancy diets were assessed using a validated FFQ from

138 Uteroplacental hypoxia is associated with pregnancy disorders such as intrauterine growth restrict

139 gy for restoring uteroplacental perfusion in pregnancy disorders.

140 Therefore, IAV infection during pregnancy drives a significant systemic vascular alterat

141 sk period for P. falciparum infection during pregnancy, especially for the youngest women.

142 Immune cells play a central role in early pregnancy establishment in cattle.

143 Use and Safety of Xolair (omalizumab) during Pregnancy (EXPECT) pregnancy registry was a prospective

144 fspring, rather than the physical process of pregnancy experienced only by females, contribute to the

145 In the per-protocol analysis restricted to pregnancies exposed to HCQ alone, 4 of 54 (7.4%) fetuses

146 ned unchanged when adjusted for mid and late pregnancy exposures.

147 butable fraction estimated for early and all pregnancy factors.

148 t their center had a formal policy regarding pregnancy following HT.

149 PM2.5 exposure during pregnancy for each participant was estimated by means of

150 bbits with cell-seeded constructs had normal pregnancies (four in ten) in the reconstructed segment o

151 regnancies]) or control (22 clusters [33 322 pregnancies]) groups.

152 Glycosuria at some point during pregnancy has an estimated prevalence of 50% and is asso

153 Maternal exercise (ME) during pregnancy has been shown to improve metabolic health in

154 Although pregnancy has evolved multiple times independently among

155 ion(1), altered diet(2) and stress(3) during pregnancy, has been increasingly associated with abnorma

156 s, those born to young mothers with repeated pregnancies have at least 0.15 (95% CI - 0.23, - 0.08) L

157 stillbirths after the inclusion of previous pregnancy history.

158 maternal insulin sensitivity changes during pregnancy; however, mechanisms remain unclear.

159 study was to describe trends in maternal pre-pregnancy hypertension among women in rural and urban ar

160 Maternal burden of pre-pregnancy hypertension has nearly doubled in the past de

161 Women with intrahepatic cholestasis of pregnancy (ICP), a disorder characterised by raised seru

162 gement of mental illness, contraception, and pregnancy improves a woman's capacity to function and op

163 nce of brain or eye defects was higher among pregnancies in which the mother had an onset of ZVD symp

164 early and late prenatal VD status in during pregnancies in women with and without asthma on childhoo

165 thway, is essential for the establishment of pregnancy in a postimplantation mammalian embryo and ind

166 nor the safety of iodine supplementation in pregnancy in areas of mild-to-moderate deficiency are we

167 ecommendations for iodine supplementation in pregnancy in areas of mild-to-moderate deficiency.

168 ith SCH when compared to women with a normal pregnancy, in the second trimester.

169 ast one follow-up visit, compared unintended pregnancy incidence between groups using discrete-time s

170 lling for the most recent CD4+ T-cell count, pregnancy incidence rates in HIV-positive women receivin

171 behaviour among female sex workers to change pregnancy incidence when used in isolation.

172 mbopag (n = 8) or romiplostim (n = 7) during pregnancy, including 2 patients with secondary ITP, were

173 nfection during pregnancy are due in part to pregnancy-induced alteration of innate immune cell frequ

174 initiation, but does not perturb the normal pregnancy-induced epigenomic landscape.

175 cental lactogen (PL) plays a crucial role in pregnancy-induced maternal beta-cell proliferation.

176 tor levels are normalized, either due to the pregnancy-induced rise of factor levels or by infusion o

177 n relation to air pollution exposures during pregnancy, infancy, and childhood in a UK population-bas

178 Pregnancy is a high-risk period for HIV acquisition in A

179 Plasmodium falciparum in pregnancy is a major cause of adverse pregnancy outcomes

180 The first trimester of pregnancy is a particularly high-risk period for P. falc

181 ition of human cytomegalovirus (HCMV) during pregnancy is a primary strategy to reduce the incidence

182 Untreated Y. pestis infection during pregnancy is associated with a high risk of maternal mor

183 to the traditional vegetables pattern before pregnancy is associated with a lower risk of preterm bir

184 We wanted to determine whether pregnancy is associated with cervical artery dissection.

185 ation of HIV antiretroviral therapy (ART) in pregnancy is associated with not achieving viral suppres

186 igated whether reduced HCV replication after pregnancy is associated with recovery of CD4+ T cell imm

187 Any alcohol use during pregnancy is associated with subtle yet significant psyc

188 nes, a significant proportion indicates that pregnancy is contraindicated in all recipients and the m

189 reproductive age, exposure to DOACs in early pregnancy is not uncommon, but data on the embryotoxic r

190 safety profile of antimicrobials used during pregnancy is one important consideration in the decision

191 ce of acquired cardiovascular disease during pregnancy is rising as older maternal age, obesity, diab

192 erformance of these diagnostic components in pregnancy is scarce.

193 le in placentally related disorders of human pregnancy is unknown(3).

194 -moderate iodine deficiency, particularly in pregnancy, is prevalent; this is of concern because obse

195 CI: 10.4, 19.9 mg . kg-1 . d-1); during late pregnancy, it was determined to be 21 mg . kg-1 . d-1 by

196 st investigate the pathogenesis of recurrent pregnancy loss and evaluate novel diagnostic tests and t

197 gress in predicting and preventing recurrent pregnancy loss has been hampered by a lack of standardiz

198 The diagnosis of an early pregnancy loss is relatively straightforward, although p

199 cted with Brucella melitensis is spontaneous pregnancy loss or vertical transmission to the fetus.

200 y could be a molecular cause for early human pregnancy loss.

201 d with a high risk of maternal mortality and pregnancy loss.

202 a small GS and a large YS reliably predicted pregnancy loss.

203 tegies for therapeutic intervention in early pregnancy loss.

204 of 172 of 5673 pregnancies (3%) resulted in pregnancy loss; after the exclusion of pregnancies affec

205 e process of decidualization is critical for pregnancy maintenance in mice and humans.

206 ting FA supplementation >= 3 months prior to pregnancy may lessen the risk of PTD associated with PM

207 ronutrient deficits during preconception and pregnancy may persist during lactation and compromise hu

208 In addition, ILC frequencies in early pregnancy may serve as predictive biomarkers for women w

209 her in women with obesity at the begining of pregnancy (mean difference: -1.24 kg; 95% CI: -2.18, -0.

210 MYC overexpression, we demonstrate that post-pregnancy MECs are resistant to the downstream molecular

211 nical acumen because many symptoms of normal pregnancy mimic those of VTE and algorithmic tools used

212 ial antenatal visit in their first or second pregnancy (n=1 393 346).

213 Results from 15 pregnant women with ITP (pregnancies, n = 17; neonates, n = 18) treated with eith

214 n models were used to assess the role of pre-pregnancy obesity as a mediator in the association betwe

215 We investigated the extent to which pre-pregnancy obesity mediates the association between mater

216 When chosen during pregnancy, omega-6 PUFA-enriched 'Western' diets can rep

217 This study investigated the impact of pregnancy on breast cancer outcomes in patients with ger

218 The impact of maternal diet during pregnancy on child neurodevelopment is of public health

219 lure affecting young women toward the end of pregnancy or in the months following delivery.

220 Acute stroke during pregnancy or within 6 weeks of childbirth is devastating

221 ere measured in maternal serum/plasma during pregnancy, or in breast milk, with different timing of s

222 ssigned to intervention (22 clusters [36 008 pregnancies]) or control (22 clusters [33 322 pregnancie

223 Pregnancy outcome data are inconsistently captured in ph

224 Information on pregnancy outcome was available in 336 (55%) of 614 preg

225 ssociated with female fertility, measured by pregnancy outcome.

226 ployed two high-quality databases with known pregnancy outcomes (n = 221).

227 plausibility of adaptively monitoring early pregnancy outcomes based on updating hCG measurements.

228 relative to total energy intake and adverse pregnancy outcomes using targeted maximum likelihood est

229 Pregnancy outcomes were self-reported, and we estimated

230 egnancy can have devastating consequences on pregnancy outcomes, fetal development, and maternal heal

231 rnal hypertension is associated with adverse pregnancy outcomes, including fetal growth restriction (

232 This study compares pregnancy outcomes, including rates of stillbirth (fetal

233 s between antenatal IPT exposure and adverse pregnancy outcomes, maternal TB, all-cause mortality, an

234 Iron disorders are associated with adverse pregnancy outcomes, yet iron homeostatic mechanisms duri

235 rum in pregnancy is a major cause of adverse pregnancy outcomes.

236 (FGR) and pre-eclampsia are severe, adverse pregnancy outcomes.

237 s on the association between HPV and adverse pregnancy outcomes.

238 This case of invasive amoebiasis in early pregnancy outside of endemic regions and several years a

239 f MMP-8 and -9 in GCF since the beginning of pregnancy (P = 0.0381; P = 0.0302, respectively).

240 4) and increased maternal systolic BP during pregnancy (p = 2.2 x 10-2).

241 rotective role for VD sufficiency throughout pregnancy, particularly in attenuating the risk conferre

242 Cox regression models adjusting for multiple pregnancies per individual.

243 ed for any malformation (exposure during any pregnancy period or the first trimester) and cardiac mal

244 d cardiac malformations (exposure during any pregnancy period).

245 odel including breast volume at the start of pregnancy, RANKL, OPG, and other factors was used to pre

246 A statistically significant difference in pregnancy rates for SRI versus IUI was detected in women

247 a-uterine slow-release insemination (SRI) on pregnancy rates in women with confirmed infertility or t

248 Annual pregnancy rates showed considerable variability, with no

249 whales were used to investigate variation in pregnancy rates through the quantification of progestero

250 g pregnant, although existing guidelines for pregnancy recommend that women who smoke should quit smo

251 Of the 172 pregnancies recorded in these women, 147 (85%, 104 liveb

252 olair (omalizumab) during Pregnancy (EXPECT) pregnancy registry was a prospective observational study

253 nal differences in maternal lifestyle during pregnancy related to congenital heart defects (CHD) in S

254 men age >=18 years in the United States with pregnancy-related hospitalizations from January 1, 2007,

255 T2D, GDM emerges in the setting of profound pregnancy-related physiologic changes in glucose metabol

256 Successful pregnancies rely on adaptations within the mother(1), in

257 n-to-treat (ITT) analysis, 4 of 54 evaluable pregnancies resulted in a primary outcome (7.4%; 90% con

258 adjusted mean LoS was calculated by level of pregnancy risk (high vs. low).

259 -RAs for severe and/or refractory ITP during pregnancy seems safe for both mother and neonate and is

260 percent (n=37) of respondents indicated that pregnancy should be avoided in all HT recipients, and on

261 Comparing lithium-exposed with unexposed pregnancies, significance remained for any malformation

262 have shown that high-fat (HF) feeding during pregnancy significantly reduces maternal blood TG levels

263 lyzed data from 1,956 males participating in Pregnancy Study Online, a preconception cohort study of

264 plantation strategies that may contribute to pregnancy success.

265 ty and the recommendation in favour of close pregnancy surveillance is still valid.

266 The 2016 ISTH guidance against elective pregnancy termination for fear of DOAC embryotoxicity an

267 74 (22%) miscarriages, and 74 (22%) elective pregnancy terminations.

268 While most recognizable in the pregnancy tests, there are many other applications for l

269 to differential maternal adaptation in early pregnancy than fetal genetics.

270 lower odds of psychological distress during pregnancy than those with no physical activity (K6 5-12:

271 A fundamental problem for the evolution of pregnancy, the most specialized form of parental investm

272 During pregnancy, the Zika flavivirus (ZIKV) infects human plac

273 Although dNK decrease during pregnancy, they remain present in decidual tissues at te

274 mothers aged 14-24 years who had no previous pregnancies, those born to young mothers with repeated p

275 all-cause mortality, and liver injury during pregnancy through 12 months postpartum.

276 diet, physical activity, and smoking during pregnancy to create a lifestyle score ranged from 0 to 1

277 is a gasotransmitter with important roles in pregnancy under both physiological and pathophysiologica

278 HDP population-based incidence expressed per-pregnancy underestimates the number of women affected by

279 ent protocols for children; care of women in pregnancy; use of pharmacotherapies, including ezetimibe

280 r elective abortions) were eligible for post-pregnancy viral load trajectory analyses (ie, had at lea

281 TFV-DP was 965 fmol/punch (IQR:691, 1166) in pregnancy vs 1406 fmol/punch (IQR:1053, 1859) postpartum

282 5% CI: 1.02, 1.03) for FA >= 3 months before pregnancy vs. 1.04 (95% CI: 1.03, 1.04) for no preconcep

283 dence rate of small bowel obstruction during pregnancy was 42.9 (95% CI 32.4-57.0/1000 person-years)

284 Psychological distress during pregnancy was assessed as moderate or severe using the K

285 operation for recurrence, while a subsequent pregnancy was associated with a 1.6-fold increased risk

286 Lithium prescribed during pregnancy was associated with higher odds of any congeni

287 > 100 BOE/day) vs. no production throughout pregnancy was associated with increased odds of LBW [odd

288 Phenylalanine requirement during early pregnancy was determined to be 15 mg . kg-1 . d-1 (95% C

289 The loss of QGIT positivity during pregnancy was explained by decreased IFNgamma production

290 gonist widely used in lupus including during pregnancy, was evaluated for efficacy in reducing the hi

291 In human pregnancies, we found that gestational diabetes also cor

292 During 2007-2017, 1 042 647 pregnancies were recorded.

293 ations of phthalate metabolites during early pregnancy were associated with lower child nonverbal IQ

294 ealth Screening Examination within 1 year of pregnancy were eligible.

295 Women seronegative at their first pregnancy with a subsequent pregnancy within 2 years hav

296 ness of intermittent preventive treatment in pregnancy with dihydroartemisinin-piperaquine (IPTp-DP)

297 tary Inflammatory Index (E-DII) score during pregnancy with emotional and behavioral symptoms of offs

298 e at their first pregnancy with a subsequent pregnancy within 2 years have the highest risk of delive

299 It affects 2% to 8% of pregnancies worldwide and causes significant maternal an

300 drogens as alternate biomarkers of near-term pregnancy would carry implications for improved monitori